Hala Zakaria
Hala Zakaria is an expert in Endocrinology at University of Sharjah (United Arab Emirates). Hala Zakaria has authored 18 publications, the most recent in 2025. SLR score: 56 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Obstetrics - Pediatrics - Gastroenterology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2021 - 2024
Number : 18
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Acute hepatitis induced by insulin overdose and oral glucose administration in a child managed under a hybrid continuous care model. PMID 40966066 — diabetes mellitus, glycogen, insulin, liver, enzymes, therapeutics, hypoglycemia, hepatitis, child | Endocrinol Diabetes Metab Case Rep | 2025 | 0 |
| Integrating Wearables Into a Hybrid Care Model: Continuous Remote Monitoring of a Diabetic Patient With Frequent Premature Ventricular Contractions Using an ŌURA Ring. PMID 40677442 — ventricular premature complexes, monitoring, ambulatory | Cureus | 2025 | 1 |
| Glucagon-Like Peptide-1 Receptor Agonists Combined With Personalized Digital Health Care for the Treatment of Metabolic Syndrome in Adults With Obesity: Retrospective Observational Study. PMID 40146920 — medical informatics, glucagon-like peptide 1, fasting, insulin resistance, glucagon-like peptide-1 receptor, cardiovascular diseases, telemedicine, obesity, weight loss, glucagon, therapeutics, triglycerides, metabolic syndrome, glucagon-like peptides, diabetes mellitus, type 2, digital health, semaglutide | Interact J Med Res | 2025 | 3 |
| New insights on genetic background of major diabetic vascular complications. PMID 39375805 — diabetes mellitus, genes, diabetic angiopathies, genetic background, diabetes complications | Diabetol Metab Syndr | 2024 | 2 |
| Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients. PMID 38774233 — diabetes mellitus, monitoring, ambulatory, endocrine system diseases, glycemic control, continuous glucose monitoring | Front Endocrinol (Lausanne) | 2024 | 6 |
LeadR Networks
Main global connection map